Yongjiang Yu

622 total citations
40 papers, 463 citations indexed

About

Yongjiang Yu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Yongjiang Yu has authored 40 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Yongjiang Yu's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Cancer, Lipids, and Metabolism (6 papers). Yongjiang Yu is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Cancer, Lipids, and Metabolism (6 papers). Yongjiang Yu collaborates with scholars based in China, United States and Japan. Yongjiang Yu's co-authors include Jun Qi, Lauren C. Harshman, Christopher J. Sweeney, Lorelei A. Mucci, Mark M. Pomerantz, Philip W. Kantoff, Wenbin Guan, Wanling Xie, Lillian Werner and Mari Nakabayashi and has published in prestigious journals such as Journal of Clinical Oncology, Acta Materialia and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Yongjiang Yu

36 papers receiving 458 citations

Peers

Yongjiang Yu
Pinbo Huang China
Zhiyuan Jiang China
Mehdi Dehghani Iran
Yang Gu China
Ching-Mei Chen Taiwan
Pengjie Wu China
Sen Wei China
Hajime Hirano Japan
Pinbo Huang China
Yongjiang Yu
Citations per year, relative to Yongjiang Yu Yongjiang Yu (= 1×) peers Pinbo Huang

Countries citing papers authored by Yongjiang Yu

Since Specialization
Citations

This map shows the geographic impact of Yongjiang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongjiang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongjiang Yu more than expected).

Fields of papers citing papers by Yongjiang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongjiang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongjiang Yu. The network helps show where Yongjiang Yu may publish in the future.

Co-authorship network of co-authors of Yongjiang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongjiang Yu. A scholar is included among the top collaborators of Yongjiang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongjiang Yu. Yongjiang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Yongjiang, et al.. (2025). Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential. Frontiers in Nutrition. 12. 1520695–1520695. 9 indexed citations
2.
Yu, Yongjiang, et al.. (2024). Early prediction of lithium battery knee point before capacity degradation. 2614–2618. 1 indexed citations
3.
4.
Sun, Yidong, et al.. (2024). Facile and efficient superhydrophobic film for radiative daytime cooling. Journal of Physics Conference Series. 2873(1). 12006–12006.
5.
Luo, Jia, Shaojun Chen, Bowen Shi, et al.. (2022). Non-drug efflux function of ABCC5 promotes enzalutamide resistance in castration-resistant prostate cancer via upregulation of P65/AR-V7. Cell Death Discovery. 8(1). 241–241. 8 indexed citations
6.
7.
Wu, Yanyuan, Bowen Shi, Fajun Qu, et al.. (2022). Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection. Frontiers in Oncology. 12. 864111–864111. 11 indexed citations
8.
Xia, Jia, Jiahui Zhang, Hailong Liu, et al.. (2021). Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via NF-κB activation. Cell Death and Disease. 12(9). 833–833. 14 indexed citations
9.
Xu, Ding, et al.. (2018). The risk factors of Urethrocutaneous fistula after hypospadias surgery in the youth population. BMC Urology. 18(1). 64–64. 28 indexed citations
10.
Zou, Xiangyu, Yongjiang Yu, Sihao Lin, et al.. (2018). Comprehensive miRNA Analysis of Human Umbilical Cord-Derived Mesenchymal Stromal Cells and Extracellular Vesicles. Kidney & Blood Pressure Research. 43(1). 152–161. 39 indexed citations
11.
Xu, Ding, Hailong Liu, Xiaoling Lin, et al.. (2017). Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist. The Aging Male. 20(4). 250–256. 11 indexed citations
12.
Yu, Yongjiang, Yu Zhang, Wenbin Guan, et al.. (2014). Androgen Receptor Promotes the Oncogenic Function of Overexpressed Jagged1 in Prostate Cancer by Enhancing Cyclin B1 Expression via Akt Phosphorylation. Molecular Cancer Research. 12(6). 830–842. 34 indexed citations
13.
Xu, Ding, Yongjiang Yu, Yunkai Zhu, et al.. (2013). A new Model Consists of Intravesical Prostatic Protrusion, Prostate Volume and Serum Prostatic-Specific Antigen in the Evaluation of Prostate Cancer. Pathology & Oncology Research. 20(2). 439–443. 8 indexed citations
14.
Yu, Yongjiang, et al.. (2013). In-Vitro and In-Vivo Imaging of Prostate Tumor Using NaYF4: Yb, Er Up-Converting Nanoparticles. Pathology & Oncology Research. 20(2). 335–341. 7 indexed citations
15.
Qi, Jun, et al.. (2013). Predictors of postoperative renal functional damage after nephron-sparing surgery. World Journal of Surgical Oncology. 11(1). 216–216. 8 indexed citations
16.
Lu, Jiahong, et al.. (2012). SU‐E‐J‐12: Initial Clinical Experiences in Using 4D‐CBCT as Image Guidance for Lung SBRT. Medical Physics. 39(6Part6). 3654–3654. 2 indexed citations
17.
Zhu, Yunkai, Yaqing Chen, Jun Jiang, et al.. (2012). Prostate cancer detection with real-time elastography using a bi-plane transducer: comparison with step section radical prostatectomy pathology. World Journal of Urology. 32(2). 329–333. 23 indexed citations
18.
Yu, Yongjiang. (2011). Satellite Attitude Determination Algorithm Based on Gyro and Star-sensor. Spacecraft Engineering. 1 indexed citations
19.
Pradhan, Anil K., Sultana N. Nahar, Maximiliano Montenegro, et al.. (2008). SU‐GG‐J‐167: Resonant X‐Ray Irradiation of High‐Z Nanoparticles for Cancer Theranostics. Medical Physics. 35(6Part8). 2718–2718. 1 indexed citations
20.
Li, Xue-Zhi, et al.. (2002). The Index of the Complex Eigenvalues of a Parity Progressive Population Operator. Journal of Mathematical Analysis and Applications. 268(2). 466–483. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pinbo Huang Breakdown of academic impact, for papers by Zhiyuan Jiang Breakdown of academic impact, for papers by Mehdi Dehghani Breakdown of academic impact, for papers by Yang Gu Breakdown of academic impact, for papers by Ching-Mei Chen Breakdown of academic impact, for papers by Pengjie Wu Breakdown of academic impact, for papers by Sen Wei Breakdown of academic impact, for papers by Hajime Hirano
Rankless by CCL
2026